The antiarrhythmic effect of enkephalinase inhibitors

Yu B. Lishmanov, L. N. Maslov, E. V. Uskinha

Учебно-научный центр "Исследовательский ядерный реактор"

Результат исследований: Материалы для журнала › Статья › рецензирование

Аннотация

The intravenous pretreatment with enkephalinase inhibitors KB 101 and acetorphan increased the heart resistance to the arrhythmogenic action of adrenaline (epinephrine). is related to activation of the δ-opioid receptors by endogenous enkephalins. At the same time, the μ-receptors and their endogenous agonists play an insignificant role in development of the antiarrhythmic effect of acetorphan. The enkephalinase inhibitors are a promising group of compounds for the development of new antiarrhythmic drugs, because these agents, in contrast to opiates, do not lead to narcotic addiction.

Язык оригинала	Английский
Число страниц	1
Журнал	Eksperimental'naya i Klinicheskaya Farmakologiya
Том	64
Номер выпуска	5
Состояние	Опубликовано - 1 янв 2001

ASJC Scopus subject areas

Toxicology
Pharmacology

Доступ к документу

Fingerprint Подробные сведения о темах исследования «The antiarrhythmic effect of enkephalinase inhibitors». Вместе они формируют уникальный семантический отпечаток (fingerprint).

Цитировать

@article{905444a97c7544bea6fc8ea041154d53,

title = "The antiarrhythmic effect of enkephalinase inhibitors",

abstract = "The intravenous pretreatment with enkephalinase inhibitors KB 101 and acetorphan increased the heart resistance to the arrhythmogenic action of adrenaline (epinephrine). is related to activation of the δ-opioid receptors by endogenous enkephalins. At the same time, the μ-receptors and their endogenous agonists play an insignificant role in development of the antiarrhythmic effect of acetorphan. The enkephalinase inhibitors are a promising group of compounds for the development of new antiarrhythmic drugs, because these agents, in contrast to opiates, do not lead to narcotic addiction.",

author = "Lishmanov, {Yu B.} and Maslov, {L. N.} and Uskinha, {E. V.}",

year = "2001",

month = jan,

day = "1",

language = "English",

volume = "64",

journal = "Eksperimental'naya i Klinicheskaya Farmakologiya",

issn = "0869-2092",

publisher = "Izdatelstvo Meditsina",

number = "5",

}

TY - JOUR

T1 - The antiarrhythmic effect of enkephalinase inhibitors

AU - Lishmanov, Yu B.

AU - Maslov, L. N.

AU - Uskinha, E. V.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - The intravenous pretreatment with enkephalinase inhibitors KB 101 and acetorphan increased the heart resistance to the arrhythmogenic action of adrenaline (epinephrine). is related to activation of the δ-opioid receptors by endogenous enkephalins. At the same time, the μ-receptors and their endogenous agonists play an insignificant role in development of the antiarrhythmic effect of acetorphan. The enkephalinase inhibitors are a promising group of compounds for the development of new antiarrhythmic drugs, because these agents, in contrast to opiates, do not lead to narcotic addiction.

AB - The intravenous pretreatment with enkephalinase inhibitors KB 101 and acetorphan increased the heart resistance to the arrhythmogenic action of adrenaline (epinephrine). is related to activation of the δ-opioid receptors by endogenous enkephalins. At the same time, the μ-receptors and their endogenous agonists play an insignificant role in development of the antiarrhythmic effect of acetorphan. The enkephalinase inhibitors are a promising group of compounds for the development of new antiarrhythmic drugs, because these agents, in contrast to opiates, do not lead to narcotic addiction.

UR - http://www.scopus.com/inward/record.url?scp=0042195110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042195110&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0042195110

VL - 64

JO - Eksperimental'naya i Klinicheskaya Farmakologiya

JF - Eksperimental'naya i Klinicheskaya Farmakologiya

SN - 0869-2092

IS - 5

ER -